Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
306 studies found for:    TRA
Show Display Options
RSS Create an RSS feed from your search for:
TRA
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: All-Trans Retinoic Acid (ATRA)
2 Active, not recruiting 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
Conditions: Neuroblastoma;   Neuroendocrine Tumor
Interventions: Drug: Retinoic Acid;   Drug: Placebo
3 Completed
Has Results
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
Conditions: Photodamaged Skin;   Wrinkles
Interventions: Drug: Retinol;   Drug: Tretinoin
4 Recruiting Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: tretinoin;   Drug: lithium carbonate;   Other: laboratory biomarker analysis
5 Unknown  Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
6 Terminated ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: ZD6474;   Drug: Retinoic Acid
7 Recruiting A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
Conditions: Photoaging;   Photodamage
Interventions: Drug: Adapalene;   Drug: Tretinoin
8 Terminated
Has Results
Atralin Gel for the Treatment of Rosacea
Condition: Rosacea
Interventions: Drug: vehicle gel;   Drug: Atralin gel
9 Completed Phase I 5-Azacytidine Plus VPA Plus ATRA
Conditions: Myelodysplastic Syndrome;   Acute Myelogenous Leukemia
Interventions: Drug: 5-Azacytidine (5-aza);   Drug: Valproic Acid;   Drug: All-Trans Retinoic Acid (ATRA)
10 Completed Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Oral isotretinoin;   Drug: Tretinoin 0,05% cream;   Drug: Sunscreen FPS 60
11 Terminated Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin
Condition: Acne Vulgaris
Interventions: Drug: Minocycline;   Drug: Minocycline plus tretinoin
12 Completed Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks
Conditions: Stretch Marks;   Striae;   Treatment
Interventions: Drug: Tretinoin cream 0.005%;   Device: Superficial Dermabrasion
13 Recruiting Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tretinoin and Arsenic Trioxide
14 Completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Promyelocytic Leukemia (M3);   Childhood Acute Promyelocytic Leukemia (M3);   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: tretinoin;   Drug: daunorubicin hydrochloride;   Drug: cytarabine;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: arsenic trioxide
15 Completed Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
Conditions: Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Skin Neoplasms
Interventions: Drug: Tretinoin 0.1% cream or placebo;   Other: Placebo
16 Not yet recruiting RA-2 13-cis Retinoic Acid (Isotretinoin)
Conditions: Male Infertility;   Klinefelter's Syndrome;   Y-chromosome Microdeletions
Intervention: Drug: 13-cis retinoic acid
17 Withdrawn Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream
Condition: Medication Reaction
Intervention: Drug: Tretinoin
18 Unknown  A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne
Condition: Acne Vulgaris
Interventions: Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;   Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
19 Unknown  Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin
Condition: Acne
Interventions: Drug: tretinoin microsphere 0.04% gel;   Drug: vehicle gel
20 Completed
Has Results
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
Condition: Photoaging
Interventions: Drug: adapalene gel, 0.3%;   Drug: tretinoin 0.05% emollient cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years